Jakarta, CNN Indonesia —
Group of vaccine experts at the World Health Organization (WHO) recommends residents with moderate and severe immune problems and the elderly who have been injected with two doses of the vaccine Sinovac and Sinopharm to get a third injection of alias booster.
Quoted from AFP, Strategic Advisory Group of Experts on Immunization (SAGE), mengatakan booster “must be given to people aged 60 years and over” people who are immunized with two doses of Sinovac and Sinopharm.
Booster with different vaccines “may also be considered based on vaccine supply and access considerations”.
In addition, this WHO expert group underlined the issue of people with moderate to severe immune disorders.
“SAGE recommends that people with moderate and severe immunodeficiency should be given additional doses of all WHO-approved vaccines as part of a major vaccination extension,” the expert group said. AFP, Monday (11/10).
“These individuals are less likely to respond appropriately to standard primary vaccination courses and are at high risk of developing severe COVID-19 illness,” the statement continued.
Kate O’Brien, WHO’s Head of Vaccines, said additional doses should be considered part of the main series of Covid-19 immunizations for people with weakened immune systems, which will be given after waiting one to three months.
This is to prevent severe symptoms, hospitalization, and death in clinical trials.
Several Covid-19 vaccines have been granted WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.
Infographic Comparison of the Decreased Effectiveness of Moderna, Pfizer, and AstraZeneca Vaccines. (Photo: CNNIndonesia/Basith Subastian)
WHO is also on the verge of making a decision on granting an emergency use list (EUL) for a vaccine produced by Bharat Biotech from India.
SAGE also does not recommend additional boosters for the general population, as already launched in some countries. SAGE said it would review the general booster dose issue on November 11.
WHO wants a moratorium on booster doses for the general public until the end of the year to prioritize the first dose in dozens of vaccine-scarce countries.
SAGE adds that when implementing these recommendations, countries should initially aim to maximize two-dose coverage in that population, and then administer a third dose, starting in the oldest age group.
according to AFP, Sinopharm vaccine is known to be used in 69 countries, while Sinovac is used in 36 countries, including Indonesia.